Lyndra Therapeutics' Once-Per-Week Schizophrenia Treatment Shines in Phase II

A Phase II schizophrenia treatment is showing promise for patients diagnosed with this complex and chronic brain disorder. The drug developed by Lyndra Therapeutics demonstrated it could provide sustained and extended levels of a commonly used medication for the condition.